<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7452913\results\search\drug\results.xml">
  <result pre="of the Food and Drug Administration (FDA) approved antiviral drugs." exact="Simeprevir" post="(SMV), Paritaprevir (PTV) and Grazoprevir (GZR) were the common"/>
  <result pre="Food and Drug Administration (FDA) approved antiviral drugs. Simeprevir (SMV)," exact="Paritaprevir" post="(PTV) and Grazoprevir (GZR) were the common leads identified"/>
  <result pre="non-structural proteins PDB, protein data bank PLpro, papain-like proteinase PTV," exact="Paritaprevir" post="RdRp, RNA-dependent RNA polymerase RMSD, root mean square deviation"/>
  <result pre="2 SAVES, Structure Analysis and Verification Server SF, Sinefungin SMV," exact="Simeprevir" post="TMHs, transmembrane helices ZBD, zinc binding domain Keywords SARS-CoV-2"/>
  <result pre="docking studies. Table 1 Drugs Abbreviation PubChem ID Inhibitors class" exact="Idoxuridine" post="IDU 5905 5-Substituted 2â€²-deoxyuridine analogues Trifluridine TFT 6256 Brivudine"/>
  <result pre="5905 5-Substituted 2â€²-deoxyuridine analogues Trifluridine TFT 6256 Brivudine BVDU 446727" exact="Vidarabine" post="VDR 21704 Nucleoside analogues Entecavir ETV 135398508 Telbivudine LdT"/>
  <result pre="TFT 6256 Brivudine BVDU 446727 Vidarabine VDR 21704 Nucleoside analogues" exact="Entecavir" post="ETV 135398508 Telbivudine LdT 159269 Foscarnet PFA 3415 Pyrophosphate"/>
  <result pre="BVDU 446727 Vidarabine VDR 21704 Nucleoside analogues Entecavir ETV 135398508" exact="Telbivudine" post="LdT 159269 Foscarnet PFA 3415 Pyrophosphate analogues Zidovudine AZT"/>
  <result pre="ETV 135398508 Telbivudine LdT 159269 Foscarnet PFA 3415 Pyrophosphate analogues" exact="Zidovudine" post="AZT 35370 Nucleoside reverse transcriptase (RT) inhibitors (NRTIs) Didanosine"/>
  <result pre="35370 Nucleoside reverse transcriptase (RT) inhibitors (NRTIs) Didanosine ddI 135398739" exact="Zalcitabine" post="ddC 24066 Stavudine d4T 18283 Lamivudine 3TC 60825 Abacavir"/>
  <result pre="transcriptase (RT) inhibitors (NRTIs) Didanosine ddI 135398739 Zalcitabine ddC 24066" exact="Stavudine" post="d4T 18283 Lamivudine 3TC 60825 Abacavir ABC 441300 Emtricitabine"/>
  <result pre="(NRTIs) Didanosine ddI 135398739 Zalcitabine ddC 24066 Stavudine d4T 18283" exact="Lamivudine" post="3TC 60825 Abacavir ABC 441300 Emtricitabine (âˆ’)FTC 60877 Nevirapine"/>
  <result pre="135398739 Zalcitabine ddC 24066 Stavudine d4T 18283 Lamivudine 3TC 60825" exact="Abacavir" post="ABC 441300 Emtricitabine (âˆ’)FTC 60877 Nevirapine NVP 4463 Nonnucleoside"/>
  <result pre="24066 Stavudine d4T 18283 Lamivudine 3TC 60825 Abacavir ABC 441300" exact="Emtricitabine" post="(âˆ’)FTC 60877 Nevirapine NVP 4463 Nonnucleoside reverse transcriptase inhibitors"/>
  <result pre="18283 Lamivudine 3TC 60825 Abacavir ABC 441300 Emtricitabine (âˆ’)FTC 60877" exact="Nevirapine" post="NVP 4463 Nonnucleoside reverse transcriptase inhibitors (NNRTIs) Delavirdine DLV"/>
  <result pre="NVP 4463 Nonnucleoside reverse transcriptase inhibitors (NNRTIs) Delavirdine DLV 5625" exact="Efavirenz" post="EFV 64139 Etravirine ETR 193962 Rilpivirine RPV 6451164 Saquinavir"/>
  <result pre="reverse transcriptase inhibitors (NNRTIs) Delavirdine DLV 5625 Efavirenz EFV 64139" exact="Etravirine" post="ETR 193962 Rilpivirine RPV 6451164 Saquinavir SQV 441243 Protease"/>
  <result pre="5625 Efavirenz EFV 64139 Etravirine ETR 193962 Rilpivirine RPV 6451164" exact="Saquinavir" post="SQV 441243 Protease inhibitors Ritonavir RTV 392622 Indinavir IDV"/>
  <result pre="ETR 193962 Rilpivirine RPV 6451164 Saquinavir SQV 441243 Protease inhibitors" exact="Ritonavir" post="RTV 392622 Indinavir IDV 5362440 Nelfinavir NFV 64143 Amprenavir"/>
  <result pre="SQV 441243 Protease inhibitors Ritonavir RTV 392622 Indinavir IDV 5362440" exact="Nelfinavir" post="NFV 64143 Amprenavir APV 65016 Atazanavir ATV 148192 Fosamprenavir"/>
  <result pre="392622 Indinavir IDV 5362440 Nelfinavir NFV 64143 Amprenavir APV 65016" exact="Atazanavir" post="ATV 148192 Fosamprenavir FPV 131536 Tipranavir TPV 54682461 Darunavir"/>
  <result pre="5362440 Nelfinavir NFV 64143 Amprenavir APV 65016 Atazanavir ATV 148192" exact="Fosamprenavir" post="FPV 131536 Tipranavir TPV 54682461 Darunavir DRV 213039 Telaprevir"/>
  <result pre="64143 Amprenavir APV 65016 Atazanavir ATV 148192 Fosamprenavir FPV 131536" exact="Tipranavir" post="TPV 54682461 Darunavir DRV 213039 Telaprevir TVR 3010818 Boceprevir"/>
  <result pre="148192 Fosamprenavir FPV 131536 Tipranavir TPV 54682461 Darunavir DRV 213039" exact="Telaprevir" post="TVR 3010818 Boceprevir BOC 10324367 Simeprevir SMV 24873435 Asunaprevir"/>
  <result pre="54682461 Darunavir DRV 213039 Telaprevir TVR 3010818 Boceprevir BOC 10324367" exact="Simeprevir" post="SMV 24873435 Asunaprevir ASV 16076883 Paritaprevir PTV 45110509 Grazoprevir"/>
  <result pre="3010818 Boceprevir BOC 10324367 Simeprevir SMV 24873435 Asunaprevir ASV 16076883" exact="Paritaprevir" post="PTV 45110509 Grazoprevir GZR 44603531 Raltegravir RAL 54671008 Integrase"/>
  <result pre="inhibitors Maraviroc MVC 3002977 Acyclovir ACV 135398513 Acyclic guanosine analogues" exact="Ganciclovir" post="GCV 135398740 Famciclovir FCV 3324 Valacyclovir VACV 135398742 Penciclovir"/>
  <result pre="3002977 Acyclovir ACV 135398513 Acyclic guanosine analogues Ganciclovir GCV 135398740" exact="Famciclovir" post="FCV 3324 Valacyclovir VACV 135398742 Penciclovir PCV 135398748 Valganciclovir"/>
  <result pre="135398513 Acyclic guanosine analogues Ganciclovir GCV 135398740 Famciclovir FCV 3324" exact="Valacyclovir" post="VACV 135398742 Penciclovir PCV 135398748 Valganciclovir VGCV 135413535 Cidofovir"/>
  <result pre="analogues Ganciclovir GCV 135398740 Famciclovir FCV 3324 Valacyclovir VACV 135398742" exact="Penciclovir" post="PCV 135398748 Valganciclovir VGCV 135413535 Cidofovir CDV 60613 Acyclic"/>
  <result pre="135398740 Famciclovir FCV 3324 Valacyclovir VACV 135398742 Penciclovir PCV 135398748" exact="Valganciclovir" post="VGCV 135413535 Cidofovir CDV 60613 Acyclic nucleoside phosphonate analogues"/>
  <result pre="3324 Valacyclovir VACV 135398742 Penciclovir PCV 135398748 Valganciclovir VGCV 135413535" exact="Cidofovir" post="CDV 60613 Acyclic nucleoside phosphonate analogues Amantadine AMT 2130"/>
  <result pre="Valganciclovir VGCV 135413535 Cidofovir CDV 60613 Acyclic nucleoside phosphonate analogues" exact="Amantadine" post="AMT 2130 Influenza virus inhibitors Ribavirin RBV 37542 Rimantadine"/>
  <result pre="Acyclic nucleoside phosphonate analogues Amantadine AMT 2130 Influenza virus inhibitors" exact="Ribavirin" post="RBV 37542 Rimantadine RIM 5071 Zanamivir ZAN 60855 Oseltamivir"/>
  <result pre="analogues Amantadine AMT 2130 Influenza virus inhibitors Ribavirin RBV 37542" exact="Rimantadine" post="RIM 5071 Zanamivir ZAN 60855 Oseltamivir OTV 65028 Laninamivir"/>
  <result pre="2130 Influenza virus inhibitors Ribavirin RBV 37542 Rimantadine RIM 5071" exact="Zanamivir" post="ZAN 60855 Oseltamivir OTV 65028 Laninamivir octanoate LO 9847629"/>
  <result pre="Zanamivir ZAN 60855 Oseltamivir OTV 65028 Laninamivir octanoate LO 9847629" exact="Peramivir" post="PRV 154234 Favipiravir FPV 492405 2.10 Preparation of protein"/>
  <result pre="that 17.64%, 26.29% and 56.07% of residues are present in" exact="alpha" post="helix, extended strand and random coil respectively (Suppl. Table"/>
  <result pre="protein, 13.85%, 29.79% and 56.36% of residues are present in" exact="alpha" post="helix, extended strand and random coil respectively. 3.3 TMHMM"/>
  <result pre="al., 2012b; Yu et al., 2012). Three lead molecules-Simeprevir (SMV)," exact="Paritaprevir" post="(PTV) and Grazoprevir (GZR) for SARS-CoV-2 Nsp13 helicase enzyme"/>
  <result pre="Structure SARS-CoV-2 Nsp13 helicase Binding energy (kcal/mol) Inhibition constant (Ki)" exact="Simeprevir" post="(SMV) Image 1 âˆ’10.42 23.00Â nM Paritaprevir (PTV) Image"/>
  <result pre="Inhibition constant (Ki) Simeprevir (SMV) Image 1 âˆ’10.42 23.00Â nM" exact="Paritaprevir" post="(PTV) Image 2 âˆ’9.70 78.25Â nM Grazoprevir (GZR) Image"/>
  <result pre="and molecular interaction between SARS-CoV-2 Nsp13 helicase enzyme and (B)" exact="Simeprevir" post="(SMV) (C) Paritaprevir (PTV) (D) Grazoprevir (GZR) (E) Scutellarin"/>
  <result pre="between SARS-CoV-2 Nsp13 helicase enzyme and (B) Simeprevir (SMV) (C)" exact="Paritaprevir" post="(PTV) (D) Grazoprevir (GZR) (E) Scutellarin (control inhibitor). The"/>
  <result pre="Molecule Structure SARS-CoV-2 Nsp14 Binding energy (kcal/mol) Inhibition constant (Ki)" exact="Paritaprevir" post="(PTV) Image 8 âˆ’13.29 181.23 pM Simeprevir (SMV) Image"/>
  <result pre="Inhibition constant (Ki) Paritaprevir (PTV) Image 8 âˆ’13.29 181.23 pM" exact="Simeprevir" post="(SMV) Image 9 âˆ’13.26 190.01 pM Grazoprevir (GZR) Image"/>
  <result pre="binding conformation and molecular interaction between SARS-CoV-2 Nsp14 and (B)" exact="Paritaprevir" post="(PTV) (C) Simeprevir (SMV) (D) Grazoprevir (GZR) (E) Sinefungin"/>
  <result pre="molecular interaction between SARS-CoV-2 Nsp14 and (B) Paritaprevir (PTV) (C)" exact="Simeprevir" post="(SMV) (D) Grazoprevir (GZR) (E) Sinefungin (control inhibitor). The"/>
  <result pre="(De Clercq and Li, 2016). Interestingly, the top 3 hits-" exact="Simeprevir" post="(SMV), Paritaprevir (PTV) and Grazoprevir (GZR) were also the"/>
  <result pre="and Li, 2016). Interestingly, the top 3 hits- Simeprevir (SMV)," exact="Paritaprevir" post="(PTV) and Grazoprevir (GZR) were also the top leads"/>
  <result pre="a set of FDA approved antiviral drugs. Three potential inhibitors-" exact="Simeprevir" post="(SMV), Paritaprevir (PTV) and Grazoprevir (GZR) were identified which"/>
  <result pre="of FDA approved antiviral drugs. Three potential inhibitors- Simeprevir (SMV)," exact="Paritaprevir" post="(PTV) and Grazoprevir (GZR) were identified which show dual"/>
  <result pre="screening identifies Pranlukast as a potential inhibitor against Plasmodium falciparum" exact="Adenosine" post="Deaminase enzymeGene Rep.62017546610.1016/j.genrep.2016.12.003 HalgrenT.A.Merck molecular force field. I. Basis,"/>
 </snippets>
</snippetsTree>
